Neurosense Therapeutics Ltd
NRSN0.940USD
+0.070+8.03%
終値 02/06, 16:00（ET）15分遅れの株価
23.12M時価総額
損失額直近12ヶ月PER
詳細情報 Neurosense Therapeutics Ltd 企業名
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Neurosense Therapeutics Ltdの企業情報
企業コードNRSN
会社名Neurosense Therapeutics Ltd
上場日Dec 09, 2021
最高経営責任者「CEO」Ben-Noon (Alon)
従業員数15
証券種類Ordinary Share
決算期末Dec 09
本社所在地11 Hamenofim St.
都市HERZLIYA
証券取引所NASDAQ OMX - NASDAQ BASIC
国Israel
郵便番号4672562
電話番号97297996183
ウェブサイトhttps://www.neurosense-tx.com/
企業コードNRSN
上場日Dec 09, 2021
最高経営責任者「CEO」Ben-Noon (Alon)
Neurosense Therapeutics Ltdの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
3.18M
+93666.00%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
480.92K
+20916.00%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
189.62K
+66667.00%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
64.00K
--
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
24.00K
--
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Caren Deardorf
Ms. Caren Deardorf
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Revital Mandil-Levin, Ph.D.
Dr. Revital Mandil-Levin, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
3.18M
+93666.00%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
480.92K
+20916.00%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
189.62K
+66667.00%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
64.00K
--
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
24.00K
--
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
収益内訳
会社から関連データがまだ開示されていません。
会社から関連データがまだ開示されていません。
事業別
地域別
会社から関連データがまだ開示されていません。
株主
更新時刻: Sat, Jan 31
更新時刻: Sat, Jan 31
株主統計
種類
株主統計
株主統計
比率
Ben-Noon (Alon)
10.69%
Rimon Gold Assets Ltd
7.76%
Eisenberg (Or)
1.62%
Tracik (Ferenc)
0.64%
Squarepoint Capital LLP
0.32%
他の
78.97%
株主統計
株主統計
比率
Ben-Noon (Alon)
10.69%
Rimon Gold Assets Ltd
7.76%
Eisenberg (Or)
1.62%
Tracik (Ferenc)
0.64%
Squarepoint Capital LLP
0.32%
他の
78.97%
種類
株主統計
比率
Individual Investor
13.78%
Corporation
7.76%
Investment Advisor/Hedge Fund
0.37%
Investment Advisor
0.35%
Research Firm
0.15%
Hedge Fund
0.07%
Bank and Trust
0.05%
他の
77.47%
機関投資家保有株
更新時刻: Thu, Jan 1
更新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
30
293.14K
0.99%
-2.10M
2025Q3
29
437.13K
1.75%
-1.60M
2025Q2
37
7.64M
31.03%
+143.76K
2025Q1
39
7.45M
37.28%
+353.50K
2024Q4
38
7.90M
34.02%
+1.29M
2024Q3
32
5.18M
22.45%
-1.31M
2024Q2
35
6.62M
30.57%
+1.57M
2024Q1
38
5.18M
33.20%
-953.28K
2023Q4
38
5.12M
32.81%
-1.05M
2023Q3
33
5.76M
47.99%
-945.27K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Ben-Noon (Alon)
3.18M
10.69%
+93.67K
+3.04%
Apr 07, 2025
Rimon Gold Assets Ltd
2.30M
7.76%
+2.30M
--
Dec 02, 2024
Eisenberg (Or)
480.92K
1.62%
+20.92K
+4.55%
Apr 07, 2025
Tracik (Ferenc)
189.62K
0.64%
+66.67K
+54.22%
Apr 07, 2025
Squarepoint Capital LLP
95.38K
0.32%
+45.45K
+91.04%
Sep 30, 2025
Russek-Blum (Niva)
75.43K
0.25%
+10.00K
+15.28%
Apr 07, 2025
Leuchtenberger (Mark W)
64.00K
0.22%
--
--
Apr 07, 2025
Morgan Stanley & Co. LLC
41.40K
0.14%
-38.50K
-48.19%
Sep 30, 2025
Meitav Investment House Ltd
40.00K
0.13%
--
--
Sep 30, 2025
Binder (Hagit)
32.00K
0.11%
+10.00K
+45.45%
Apr 07, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
